As of 2025-01-14, the Relative Valuation of Haemonetics Corp (HAE) is 85.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 79.41 USD, the upside of Haemonetics Corp based on Relative Valuation is 7.2%.
The range of the Relative Valuation is 73.43 - 98.71 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.6x - 37.4x | 33.7x |
| Forward P/E multiples | 22.9x - 30.8x | 27.2x |
| Fair Price | 73.43 - 98.71 | 85.15 |
| Upside | -7.5% - 24.3% | 7.2% |
| Date | P/E |
| 2025-01-10 | 31.10 |
| 2025-01-08 | 31.68 |
| 2025-01-07 | 31.52 |
| 2025-01-06 | 31.97 |
| 2025-01-03 | 32.47 |
| 2025-01-02 | 31.80 |
| 2024-12-31 | 31.67 |
| 2024-12-30 | 31.07 |
| 2024-12-27 | 31.46 |
| 2024-12-26 | 31.98 |
| 2024-12-24 | 31.40 |
| 2024-12-23 | 31.31 |
| 2024-12-20 | 30.60 |
| 2024-12-19 | 31.19 |
| 2024-12-18 | 31.95 |
| 2024-12-17 | 33.29 |
| 2024-12-16 | 33.36 |
| 2024-12-13 | 32.93 |
| 2024-12-12 | 33.38 |
| 2024-12-11 | 33.80 |
| 2024-12-10 | 34.02 |
| 2024-12-09 | 33.64 |
| 2024-12-06 | 32.93 |
| 2024-12-05 | 32.72 |
| 2024-12-04 | 33.87 |
| 2024-12-03 | 34.58 |
| 2024-12-02 | 35.48 |
| 2024-11-29 | 35.48 |
| 2024-11-27 | 35.65 |
| 2024-11-26 | 35.91 |
| 2024-11-25 | 35.88 |
| 2024-11-22 | 34.70 |
| 2024-11-21 | 34.65 |
| 2024-11-20 | 34.44 |
| 2024-11-19 | 34.41 |
| 2024-11-18 | 35.76 |
| 2024-11-15 | 36.19 |
| 2024-11-14 | 36.81 |
| 2024-11-13 | 37.23 |
| 2024-11-12 | 37.88 |
| 2024-11-11 | 37.07 |
| 2024-11-08 | 35.46 |
| 2024-11-07 | 35.10 |
| 2024-11-06 | 31.70 |
| 2024-11-05 | 30.41 |
| 2024-11-04 | 29.82 |
| 2024-11-01 | 28.99 |
| 2024-10-31 | 28.86 |
| 2024-10-30 | 29.21 |
| 2024-10-29 | 29.65 |